- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MSC1936369B (pimasertib)
Total 19 results
-
Merck KGaA, Darmstadt, GermanyCompletedLocally Advanced or Metastatic Solid TumorsHungary
-
EMD SeronoTerminatedMetastatic Colorectal CancerItaly, Spain, Belgium
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
EMD SeronoCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedCancer | Solid TumorsFrance, Belgium, Australia, Netherlands
-
EMD SeronoTerminatedLeukemia, Myeloid, Acute | Hematologic NeoplasmsUnited States, France
-
EMD SeronoSanofiCompletedMelanoma | Breast Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Italy, Spain
-
SanofiCompletedSolid TumorsUnited States
-
SanofiMerck KGaA, Darmstadt, GermanyCompletedNeoplasm MalignantNetherlands, France
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPancreatic AdenocarcinomaUnited States, Germany
-
EMD SeronoTerminated
-
EMD SeronoSanofiCompletedOvarian CancerUnited States, Belgium, Canada, Australia, Spain, France, Poland
-
M.D. Anderson Cancer CenterCompletedHematopoietic and Lymphoid Cell Neoplasm | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Stage IV Lung Cancer AJCC v8 | Metastatic... and other conditionsUnited States
-
Diakonhjemmet HospitalOslo University Hospital; University Hospital of North Norway; Helse Nord-Trøndelag... and other collaboratorsRecruitingImmune-related Adverse EventNorway
-
Merck KGaA, Darmstadt, GermanyMerck Serono Co., Ltd., JapanTerminatedHepatocellular Carcinoma | Advanced Solid TumorsJapan
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
BeiGeneActive, not recruitingRecurrent or Metastatic Nasopharyngeal CancerChina, Taiwan, Thailand
-
Australian & New Zealand Children's Haematology...The Hospital for Sick Children; Kazia Therapeutics Limited; Day One Biopharmaceuticals... and other collaboratorsNot yet recruitingChildhood Cancer | Refractory Cancer | Recurrent Cancer | Childhood Solid Tumor | Childhood Brain TumorAustralia, Canada
-
Nehal Abou SeadaCompletedNon-Alcoholic Fatty Liver Disease